Topical solutions for the treatment of nasal symptoms in the common cold for newborn infants, children and adults
CA 2361345 A1 · Owner: Levy, Maurice · Inventors: Levy, Maurice
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Common cold is a viral infection resulting predominantly in inflammation of the nasal, mucosa. The most prevalent symptoms are nasal congestion (resulting in obstruction), and nasal discharge. The solutions proposed are intended for topical intranasal use in newborn infants, young, and older children, and adults. The main ingredients concentration will vary according to, the patient's age, effects and side effects observed during the studies. The main ingredient of these solutions is the steroid Bethamethasone or , Dexamethasone. These can be used alone or in combination with an Aminoglycoside antibiotic (Tobramycin or Gentamycin) and/or an anticholinergic agent such as Ipatropium, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 19, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 19, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 19, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.